Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 197

Similar articles for PubMed (Select 23018061)

1.

Recombinant envelope protein-based enzyme immunoassay for IgG antibodies is comparable to neutralization tests for epidemiological studies of dengue infection.

Rocha ES, Oliveira JG, Santos JR, Rodrigues GO, Figueiredo LB, Pessanha JE, Proietti FA, Fonseca FG, Bonjardim CA, Ferreira PC, Kroon EG.

J Virol Methods. 2013 Jan;187(1):114-20. doi: 10.1016/j.jviromet.2012.09.012. Epub 2012 Sep 24.

2.

Evaluation of recombinant dengue viral envelope B domain protein antigens for the detection of dengue complex-specific antibodies.

Simmons M, Porter KR, Escamilla J, Graham R, Watts DM, Eckels KH, Hayes CG.

Am J Trop Med Hyg. 1998 Feb;58(2):144-51.

3.

[Establishment and preliminary application of dengue virus envelope domain III IgG antibody capture enzyme-linked immuno-absorbent assay].

Hu DM, Cai JP, Wang DH, DI B, Qiu LW, Wang YD, Chen Y, Ding XX, Che XY.

Zhonghua Yu Fang Yi Xue Za Zhi. 2013 Apr;47(4):363-6. Chinese.

PMID:
23928645
4.

[Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey].

Ergünay K, Saygan MB, Aydoğan S, Litzba N, Niedrig M, Pınar A, Us D.

Mikrobiyol Bul. 2010 Jul;44(3):415-24. Turkish.

PMID:
21063991
5.

Optimization of the cutoff value for a commercial anti-dengue virus IgG immunoassay.

Marrero-Santos KM, Beltrán M, Carrión-Lebrón J, Sanchez-Vegas C, Hamer DH, Barnett ED, Santiago LM, Hunsperger EA.

Clin Vaccine Immunol. 2013 Mar;20(3):358-62. doi: 10.1128/CVI.00429-12. Epub 2013 Jan 9.

6.

Comparison of plaque- and enzyme-linked immunospot-based assays to measure the neutralizing activities of monoclonal antibodies specific to domain III of dengue virus envelope protein.

Liu L, Wen K, Li J, Hu D, Huang Y, Qiu L, Cai J, Che X.

Clin Vaccine Immunol. 2012 Jan;19(1):73-8. doi: 10.1128/CVI.05388-11. Epub 2011 Nov 23.

7.

[To evaluate the neutralizing abilities of anti-dengue virus antibodies with nonstructural protein 1 antigen capture enzyme-linked immunosorbent assay].

Wen K, Ding YQ, Qiu LW, Pan YX, Cai JP, Yue CF, DI B, Che XY.

Zhonghua Yu Fang Yi Xue Za Zhi. 2009 Aug;43(8):680-5. Chinese.

PMID:
20021846
9.

Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000.

Chang SF, Huang JH, Chen LK, Su CL, Liao TL, Chien LJ, Lin TH, Su CJ, Shu PY.

J Microbiol Immunol Infect. 2008 Oct;41(5):377-85.

PMID:
19122918
10.

Analysis of recombinant dengue virus polypeptides for dengue diagnosis and evaluation of the humoral immune response.

dos Santos FB, Miagostovich MP, Nogueira RM, Schatzmayr HG, Riley LW, Harris E.

Am J Trop Med Hyg. 2004 Aug;71(2):144-52.

11.

Recombinant polypeptide antigen-based immunoglobulin G enzyme-linked immunosorbent assay for serodiagnosis of dengue.

Dos Santos FB, Nogueira RM, Lima MR, De Simone TS, Schatzmayr HG, Lemes EM, Harris E, Miagostovich MP.

Clin Vaccine Immunol. 2007 May;14(5):641-3. Epub 2007 Mar 28.

12.
13.

Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodies.

Putnak JR, de la Barrera R, Burgess T, Pardo J, Dessy F, Gheysen D, Lobet Y, Green S, Endy TP, Thomas SJ, Eckels KH, Innis BL, Sun W.

Am J Trop Med Hyg. 2008 Jul;79(1):115-22.

14.

[Prevalence of neutralizing antibodies to dengue virus serotypes in university students from Tabasco, Mexico].

Sánchez-Burgos GG, López-Alvarado MA, Castañeda-Desales D, Ruiz-Gómez J, Ramos-Castañeda J.

Salud Publica Mex. 2008 Sep-Oct;50(5):362-6. Spanish.

15.

Evaluation of envelope domain III-based single chimeric tetravalent antigen and monovalent antigen mixtures for the detection of anti-dengue antibodies in human sera.

Batra G, Nemani SK, Tyagi P, Swaminathan S, Khanna N.

BMC Infect Dis. 2011 Mar 15;11:64. doi: 10.1186/1471-2334-11-64.

16.

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.

de Alwis R, Smith SA, Olivarez NP, Messer WB, Huynh JP, Wahala WM, White LJ, Diamond MS, Baric RS, Crowe JE Jr, de Silva AM.

Proc Natl Acad Sci U S A. 2012 May 8;109(19):7439-44. doi: 10.1073/pnas.1200566109. Epub 2012 Apr 12.

17.

Prevalence of dengue virus infection in US travelers who have lived in or traveled to dengue-endemic countries.

Sanchez-Vegas C, Hamer DH, Chen LH, Wilson ME, Benoit C, Hunsperger E, Macleod WB, Jentes ES, Ooi WW, Karchmer AW, Kogelman L, Yanni E, Marano N, Barnett ED.

J Travel Med. 2013 Nov-Dec;20(6):352-60. doi: 10.1111/jtm.12057. Epub 2013 Aug 16.

PMID:
24165381
18.

Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases.

Lai CY, Williams KL, Wu YC, Knight S, Balmaseda A, Harris E, Wang WK.

PLoS Negl Trop Dis. 2013 Sep 19;7(9):e2451. doi: 10.1371/journal.pntd.0002451. eCollection 2013.

19.

Single antigen detects both immunoglobulin M (IgM) and IgG antibodies elicited by all four dengue virus serotypes.

Hapugoda MD, Batra G, Abeyewickreme W, Swaminathan S, Khanna N.

Clin Vaccine Immunol. 2007 Nov;14(11):1505-14. Epub 2007 Sep 26.

20.

Detection of serotype-specific antibodies to the four dengue viruses using an immune complex binding (ICB) ELISA.

Emmerich P, Mika A, Schmitz H.

PLoS Negl Trop Dis. 2013 Dec 26;7(12):e2580. doi: 10.1371/journal.pntd.0002580. eCollection 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk